IntelGenx Technologies Corp. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 55 rows in 2023. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-09-30: Reporting owner ATAI Life Sciences N.V. | ATAI Life Sciences AG; Form 4; Security Call Option (Right to Buy); Transaction J Other acquisition or disposition (describe transaction).
- 2023-04-20: Reporting owner Gorham Dwight; Form 3; Security Options, right to buy (p.v. 0.00001); Transaction Holding.
- 2023-04-20: Reporting owner Gorham Dwight; Form 3; Security Options, right to buy (p.v. 0.00001); Transaction Holding.
- 2023-04-20: Reporting owner Gorham Dwight; Form 3; Security Options, right to buy (p.v. 0.00001); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | ATAI Life Sciences N.V. | ATAI Life Sciences AG 10% Owner | 10% Owner | 4 | Call Option (Right to Buy) Derivative · Indirect · By ATAI Life Sciences AG | J Other acquisition or disposition (describe transaction) | +7,401 7,401 owned after | no price filed | 2024-03-12 | |
| 2023-04-20 holding as of filing | Gorham Dwight Officer (CEO) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.16 exercise price | 2023-04-20 | ||
| 2023-04-20 holding as of filing | Gorham Dwight Officer (CEO) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.16 exercise price | 2023-04-20 | ||
| 2023-04-20 holding as of filing | Gorham Dwight Officer (CEO) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.16 exercise price | 2023-04-20 | ||
| 2023-04-20 holding as of filing | Gorham Dwight Officer (CEO) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.16 exercise price | 2023-04-20 | ||
| 2023-04-20 holding as of filing | Gorham Dwight Officer (CEO) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.16 exercise price | 2023-04-20 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.73 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.76 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.27 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.44 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.44 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.44 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.24 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.24 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.24 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.24 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.19 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.19 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.19 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kalayajian Karen Officer (VP, Finance&Admin - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.19 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kideckel David Officer (SVP, Corp. Dev&SA - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.19 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kideckel David Officer (SVP, Corp. Dev&SA - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.19 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kideckel David Officer (SVP, Corp. Dev&SA - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.19 exercise price | 2023-04-19 | ||
| 2023-04-19 holding as of filing | Kideckel David Officer (SVP, Corp. Dev&SA - Subsidiary) | 3 | Options, right to buy (p.v. 0.00001) Derivative · Direct | Holding | $0.19 exercise price | 2023-04-19 | ||
| 2023-04-04 | Godin Andre Officer (President & CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +500,000 1,593,720 owned after | $0.19 exercise price | 2023-04-10 | |
| 2023-04-04 | Godin Andre Officer (President & CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +500,000 2,093,720 owned after | $0.19 exercise price | 2023-04-10 | |
| 2023-04-04 | Kenny Tommy Officer (VP IP Legal Affairs-Subsidiary) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 262,500 owned after | $0.19 exercise price | 2023-04-10 | |
| 2023-04-04 | Kenny Tommy Officer (VP IP Legal Affairs-Subsidiary) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 287,500 owned after | $0.19 exercise price | 2023-04-10 | |
| 2023-04-04 | Kenny Tommy Officer (VP IP Legal Affairs-Subsidiary) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 300,000 owned after | $0.19 exercise price | 2023-04-10 | |
| 2023-04-04 | Kenny Tommy Officer (VP IP Legal Affairs-Subsidiary) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 325,000 owned after | $0.19 exercise price | 2023-04-10 | |
| 2023-04-04 | Kenny Tommy Officer (VP IP Legal Affairs-Subsidiary) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 375,000 owned after | $0.19 exercise price | 2023-04-10 | |
| 2023-01-29 | Matzen Dana Officer (VP Business & Corp. Dev) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 472,470 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Matzen Dana Officer (VP Business & Corp. Dev) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 484,970 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Matzen Dana Officer (VP Business & Corp. Dev) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 497,470 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Matzen Dana Officer (VP Business & Corp. Dev) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 509,970 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Kenny Tommy Officer (VP IP Legal Affairs-Subsidiary) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 262,500 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Kenny Tommy Officer (VP IP Legal Affairs-Subsidiary) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 275,000 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Kenny Tommy Officer (VP IP Legal Affairs-Subsidiary) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 287,500 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Kenny Tommy Officer (VP IP Legal Affairs-Subsidiary) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 300,000 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Paiement Nadine Officer (VP R & D, IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,250 266,220 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Paiement Nadine Officer (VP R & D, IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,250 272,470 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Paiement Nadine Officer (VP R & D, IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,250 278,720 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Paiement Nadine Officer (VP R & D, IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,250 284,970 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Godin Andre Officer (President & CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +33,750 1,093,720 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Godin Andre Officer (President & CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +33,750 1,127,470 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Godin Andre Officer (President & CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +33,750 1,161,220 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Godin Andre Officer (President & CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +33,750 1,194,970 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Zerbe Ingrid Officer (Corporate Secretary) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,250 6,250 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Zerbe Ingrid Officer (Corporate Secretary) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,250 12,500 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Zerbe Ingrid Officer (Corporate Secretary) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,250 18,750 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Zerbe Ingrid Officer (Corporate Secretary) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,250 25,000 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Zerbe Horst G Director, Officer (Chief Executive Officer) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 617,408 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Zerbe Horst G Director, Officer (Chief Executive Officer) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 654,908 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Zerbe Horst G Director, Officer (Chief Executive Officer) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 692,408 owned after | $0.24 exercise price | 2023-01-31 | |
| 2023-01-29 | Zerbe Horst G Director, Officer (Chief Executive Officer) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 729,908 owned after | $0.24 exercise price | 2023-01-31 |